Regulation of tumour necrosis factor signalling: live or let die

Nat Rev Immunol. 2015 Jun;15(6):362-74. doi: 10.1038/nri3834.

Abstract

Tumour necrosis factor (TNF) is a pro-inflammatory cytokine that has important roles in mammalian immunity and cellular homeostasis. Deregulation of TNF receptor (TNFR) signalling is associated with many inflammatory disorders, including various types of arthritis and inflammatory bowel disease, and targeting TNF has been an effective therapeutic strategy in these diseases. This Review focuses on the recent advances that have been made in understanding TNFR signalling and the consequences of its deregulation for cellular survival, apoptosis and regulated necrosis. We discuss how TNF-induced survival signals are distinguished from those that lead to cell death. Finally, we provide a brief overview of the role of TNF in inflammatory and autoimmune diseases, and we discuss up-to-date and future treatment strategies for these disorders.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Activation, Metabolic / immunology
  • Animals
  • Apoptosis / immunology*
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / immunology*
  • Cell Communication / immunology*
  • Homeostasis / immunology
  • Humans
  • Inflammation / drug therapy
  • Inflammation / immunology*
  • Membrane Microdomains / immunology
  • NF-kappa B / immunology*
  • Tumor Necrosis Factor-alpha / immunology*
  • Ubiquitination / immunology

Substances

  • NF-kappa B
  • Tumor Necrosis Factor-alpha